Cite
Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.
MLA
Chuang-Wei Wang, et al. “Randomized, Controlled Trial of TNF-α Antagonist in CTL-Mediated Severe Cutaneous Adverse Reactions.” Journal of Clinical Investigation, vol. 128, no. 3, Mar. 2018, pp. 985–96. EBSCOhost, https://doi.org/10.1172/JCI93349.
APA
Chuang-Wei Wang, Lan-Yan Yang, Chun-Bing Chen, Hsin-Chun Ho, Shuen-Iu Hung, Chih-Hsun Yang, Chee-Jen Chang, Shih-Chi Su, Rosaline Chung-Yee Hui, See-Wen Chin, Li-Fang Huang, Yang Yu-Wei Lin, Wei-Yang Chang, Wen-Lang Fan, Chin-Yi Yang, Ji-Chen Ho, Ya-Ching Chang, Chun-Wei Lu, Wen-Hung Chung, & Wang, C.-W. (2018). Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions. Journal of Clinical Investigation, 128(3), 985–996. https://doi.org/10.1172/JCI93349
Chicago
Chuang-Wei Wang, Lan-Yan Yang, Chun-Bing Chen, Hsin-Chun Ho, Shuen-Iu Hung, Chih-Hsun Yang, Chee-Jen Chang, et al. 2018. “Randomized, Controlled Trial of TNF-α Antagonist in CTL-Mediated Severe Cutaneous Adverse Reactions.” Journal of Clinical Investigation 128 (3): 985–96. doi:10.1172/JCI93349.